SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-780888
Filing Date
2016-11-30
Accepted
2016-11-30 16:06:02
Documents
3
Period of Report
2016-11-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d294972d8k.htm 8-K 17506
2 EX-99.1 d294972dex991.htm EX-99.1 12533
3 GRAPHIC g294972image0001.jpg GRAPHIC 7287
  Complete submission text file 0001193125-16-780888.txt   41658
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 162025373
SIC: 2834 Pharmaceutical Preparations